AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
This piece breaks down why Total Market Return 2024 matters, highlighting drivers, risks, and practical steps to align holdings with your goals.
28,491 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Binance withdraws its Greece bid and says it has one week to secure an EU license. The company reiterates that binanc...
A notable analyst warns of a potential slide to $40,000 for Bitcoin, even as other models see a bottom in the $50,000...
Ethereum trades near $1,780 as Vitalik Buterin outlines Lean Ethereum, a multi-year overhaul that could redefine data...
The SEC is poised to publish three crypto rulemaking proposals in July, potentially beginning formal regulation befor...
XRP remains in a tight battle between support and supply as July markets unfold. A breach of key levels could set XR...
Keysight Technologies surged to an all-time high after posting a stronger-than-expected Q1 FY2026, driven by AI infra...
Fed minutes reveal a widening rift among policymakers: while the Fed kept rates steady, some officials signaled possi...
President Donald Trump steps back into the crypto policy debate, accusing banks of blocking progress on GENIUS Act an...
Marvell Technology defied earlier sell-offs tied to fears of losing Amazon and Microsoft to rivals, reporting strong ...
Bitcoin trades near the mid-$60,000s after testing $70,000 earlier this week. Analysts say long-term holder activity ...
EverCommerce stock has faced volatility in 2026. With a focus on cash flow, analysts weigh a path to a $12 target, de...